Financière de Tubize SA (EBR:TUBAT)

Market Cap	10.23B +6.1%
Revenue (ttm)	n/a
Net Income	98.41M +6.1%
EPS	2.21 +6.1%
Shares Out	n/a
PE Ratio	0.05
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	0.1000
Day's Range	n/a
52-Week Range	0.1000 - 0.1000
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 20, 2027

About Financière de Tubize

Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium. It focuses on the discovery and development of treatments for patients suffering from diseases affecting immune or central nervous system. The company was founded in 1928 and is based in Brussels, Belgium.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1928
• Employees: 3
• Stock Exchange: Euronext Brussels
• Ticker Symbol: TUBAT

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 30, 2026

Data Sources Report a data error